Trial document




drksid header

  DRKS00013202

Trial Description

start of 1:1-Block title

Title

Katamnesis regarding symptom development and health care utilization after in-Patient psychosomatic-psychotherapeutic treatment

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

Psychosom-Kat

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

Former psychosomatic-psychotherapeutic in-patients (treatment after August 2016) shall be examined each year by questionnaires regarding their symptoms and utilization of the health care system. We will also try to identify predictors of a positive outcome.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

Patients who underwent inpatient psychosomatic-psychotherapeutic treatment in a multimodal psychodynamic setting after August 2016, are contacted every year after their dismission and examined by standardized questionnaires which assess symptoms and resources (Patient Health Questionnaire (PHQ), Eating Disorder Examination Questionnaire (EDE-Q), Pain Disability Index (PDI), Posttraumatic Diagnostic Scale (PDS), Resiliency Scale (RS-13), Sense of Coherence Scale (SOC-13), OPD-Structure-Questionnaire (OPD-SF12). They also are asked to complete a questionnaire on their subjective assessment of the treatment success and utilization of medical services.
These are the same questionnaires which they completed at the beginning and end of their inpatient treatment, supplemented by the Childhood Trauma Questionnaire (CTQ). Their therapists assessed their patients by Operationalized Psychodynamic Diagnostic (OPD-2) and the psychodynamic treatment foci by the Heidelberg Structural Change Scale.
We intend to assess the symptom course and identify predictors of short term and long term therapeutic success.

end of 1:1-Block scientific synopsis
start of 1:1-Block forwarded Data

Do you plan to share individual participant data with other researchers?

[---]*

end of 1:1-Block forwarded Data
start of 1:1-Block forwarded Data Content

Description IPD sharing plan:

[---]*

end of 1:1-Block forwarded Data Content
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00013202
  •   2017/10/23
  •   [---]*
  •   yes
  •   Approved
  •   2009-205-f-S, Ethik-Kommission der Ärztekammer Westfalen-Lippe und der med. Fakultät der Westfälischen Wilhelms-Universität Münster
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   F32 -  Depressive episode
  •   F33 -  Recurrent depressive disorder
  •   F34 -  Persistent mood [affective] disorders
  •   F40 -  Phobic anxiety disorders
  •   F41 -  Other anxiety disorders
  •   F42 -  Obsessive-compulsive disorder
  •   F43 -  Reaction to severe stress, and adjustment disorders
  •   F44 -  Dissociative [conversion] disorders
  •   F45 -  Somatoform disorders
  •   F48 -  Other neurotic disorders
  •   F50 -  Eating disorders
  •   F60 -  Specific personality disorders
  •   F61 -  Mixed and other personality disorders
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   Former psychosomatic-psychotherapeutic in-patients, who were treated starting with August 2016, shall be examined each year by questionnaires regarding their symptoms and utilization of the health care system.
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Non-interventional
  •   Observational study
  •   Single arm study
  •   Open (masking not used)
  •   [---]*
  •   Uncontrolled/Single arm
  •   Prognosis
  •   Single (group)
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

Symptom and resources development is measured 1 year after the inpatient treatment and then yearly by means of standardized questionnaires, which the patients also completed during inpatient treatment: Patient Health Questionnaire (PHQ), Eating Disorder Examination Questionnaire (EDE-Q), Pain Disability Index (PDI), Posttraumatic Diagnostic Scale (PDS), Resiliency Scale (RS-13), Sense of Coherence Scale (SOC-13), OPD-Structure-Questionnaire (OPD-SF12).

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

The subjective assessment of the treatment success and utilization of medical Services is measured one year after the inpatient treatment and then yearly by means of a questionnaire.

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • University Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Planned
  •   2017/11/01
  •   1000
  •   Monocenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   18   Years
  •   no maximum age
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

all former in-patients of our department who were treated starting with August 2016 and agreed to katamnesis

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

none

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Klinik für Psychosomatik und PsychotherapieUKM
    • Ms.  Prof.Dr.med.  Gudrun  Schneider 
    • Domagkstr.22
    • 48149  Münster
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address scientific-contact
    • Klinik für Psychosomatik und Psychotherapie UKM
    • Ms.  Prof.Dr.med.  Gudrun  Schneider 
    • Domagkstr.22
    • 48149  Münster
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Klinik für Psychosomatik und Psychotherapie UKM
    • Ms.  Prof.Dr.med.  Gudrun  Schneider 
    • Domagkstr.22
    • 48149  Münster
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Klinik für Psychosomatik und Psychotherapie UKM
    • Domagkstr.22
    • 48149  Münster
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    •   0251-8352902
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting planned
  •   [---]*
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.